Sparing paclitaxel by the use of hyaluronan

Details Sparing paclitaxel by the use of hyaluronan Sparing paclitaxel by the use of hyaluronan

A - Human Necessities

61

K

A61K 45/06 (2006.01) A61K 47/36 (2006.01)

Patent

CA 2208924

This invention relates to the use of forms of hyaluronan for use to deliver effective dosage amounts of the agent paclitaxel sold under the trade mark "Taxol" to a patient which medicine is present in a dosage amount much less than the usual amount presently being used when treating a patient with cancer.

L'invention concerne l'utilisation de formes d'hyaluronan pour administrer des doses efficaces de l'agent paclitaxel vendu sous le nom de marque « Taxol » à un patient dont la dose de médicament à prendre est beaucoup inférieure à la quantité habituelle couramment utilisée pour traiter un cancéreux.

Affiliated with

Also associated with

Rating

Sparing paclitaxel by the use of hyaluronan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sparing paclitaxel by the use of hyaluronan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sparing paclitaxel by the use of hyaluronan will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1965698